Auris Medical Holding AG (EARS)

0.24 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.24

Price Open 0.24

Volume: 80

Avg Volume: 855,965

Market Cap: 1.47M

P/E Ratio -

52 Wk Range 0.23-9.5



EARS Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
6.12M
403,729
0.34
6.60%

2018-07-13
6.12M
734,759
0.94
12.01%

2018-06-29
6.12M
611,595
4.28
10.00%

2018-06-15
6.12M
513,245
2.05
8.39%




EARS Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-03-27
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-03-22
Q4 2017
N/A
0.00 (0)
-1.01
0.00

2018-03-20
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-03-13
Q4 2017
N/A
0.00 (0)
0.00
0.00

News

Auris Medical Holding 2018 Q2 - Results - Earnings Call Slides (2018-08-15 12:22 SeekingAlpha)

The following slide deck was published by Auris Medical Holding in conjunction with their 2018 Q2 earnings Read more …

 

Auris Medical's (EARS) CEO Thomas Meyer on Q2 2018 Results - Earnings Call Transcript (2018-08-15 12:13 SeekingAlpha)

Auris Medical Holding (EARS) Q2 2018 Earnings Conference Call August 15, 2018 08:00 AM ET Executives Hernan Levett Chief Financial Officer Thomas Meyer Chairman and Chief Executive Officer Analysts Juan Serrate Edison Presentation Operator …

 

Auris Medical up 3% premarket on Q2 results (2018-08-15 07:44 SeekingAlpha)

Auris Medical ( EARS ) Q2 results (CHF): Revenues: 0; Net Loss: (3.1M) (+42.6%); Loss Per Share: (0.50) (+59.0%); Quick Assets: 4.4M (-70.7%). More news on: Auris Medical Holding, Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more …

 

Auris Medical reports Q2 results (2018-08-15 06:53 SeekingAlpha)

Auris Medical (NASDAQ: EARS ): Q2 EPS of -CHF0.50 Cash and cash equivalents CHF4.42M Press Release More news on: Auris Medical Holding, Earnings news and commentary, Healthcare stocks news, ,

 


Statistics

Shares Outstanding: 6.12M

Top 15 Institution Percent: 13.10

Price To Sales: N/A

Price To Book: 6.52

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -69.55

Return On Equity: -411.55

Profit Margin: N/A

Price History

Beta: 0.32

50-day Moving Avg: 0.58

200-day Moving Avg: 2.79

YTD Change: -96.13

5-day Change: -5.40

1-month Change: -14.29

3-month Change: -83.56

6-month Change: -91.65

1-year Change: -96.76

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Auris Medical Holding AG

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.aurismedical.com

Auris Medical Holding AG is a clinical-stage biopharmaceutical company. It is engaged in the development of novel products for the treatment of inner ear disorders. Its product candidate is AM-101.